The internationally active ENGEL Group closed FY 2025/26 with revenue of EUR 1.4 billion, slightly below the previous year’s level (-6%). The company also reported securing several major customer projects in the United States involving technologically advanced applications. According to the company, this confirms the importance of the US as its most significant addressable market. The past financial year unfolded amid structural changes across the industry, varying regional investment dynamics and continued cost pressures. In Europe, market conditions remained challenging, while in the US investment activity, as ENGEL reports, accelerated again. Asia as a whole proved resilient, with Southeast Asia and India in particular said to provide important growth stimulus as future-oriented markets. Growth was primarily driven by technologically sophisticated applications.
Segments and growth drivers
ENGEL states that the technical injection moulding segment performed well, supported by orders from sectors including logistics and aerospace. The medical segment continued to operate at a high level, while packaging developed more cautiously. "The challenges persist in what remains a highly volatile global environment," said Stefan Engleder, CEO of the ENGEL Group. "We remain firmly committed to strengthening our global footprint and our high-performance sales and service organisation, enabling us to support our customers worldwide and create tangible added value for their success. Against this backdrop, ENGEL is advancing its internal transformation programme as planned, with the clear objective of further securing its long-term competitiveness."
Transformation and global manufacturing footprint
According to the company, its international production sites, established over several decades, together with its Austrian locations, which are being strategically aligned as part of the transformation initiative, form a global manufacturing network designed to meet evolving customer requirements. At the Changzhou plant in China alone, more than 1,000 injection moulding machines were produced in FY 2025/26. A further approximately 700 machines were manufactured across facilities in Shanghai and in Korea.
Dual-brand strategy: ENGEL and Wintec
The strong manufacturing footprint in Asia is intended to support the further rollout of the dual-brand strategy. Engel focuses on customised solutions for highly demanding applications. Wintec, described by the company as the Group’s increasingly important second brand, complements the portfolio with standardised solutions for clearly defined applications, prioritising cost efficiency and rapid availability, and leveraging automation and digital technologies.
Call for long-term industrial policy in Europe
In parallel with internal measures, ENGEL emphasises the importance of favourable economic policy conditions in Europe. The company argues that reliable planning frameworks and fair competitive conditions are essential to safeguard long-term industrial investment. "Europe needs a stable, long-term industrial policy once again. This includes fair competitive conditions to ensure that industrial investment remains predictable," Engleder added.
The headquarters of the ENGEL Group in Schwertberg, Austria
